In Vitro Proliferation and Expansion of Hematopoietic Progenitors from Patients with Diffuse Large B-Cell Lymphoma Before and After Chemotherapy

Reference

• Coiffier, B. (2001) "Diffuse large cell lymphoma", Current Opinion in Oncology, 13, 325–334.
   PubMed Web of Science ®Google Scholar
• Ortega, V., Verastegui, E., Flores, G., Meneses, A., Ocadiz R. and Alfaro, G. (1998) "Non-Hodgkin's lymphomas in Mexico. A clinicopathological and molecular analysis", Leukemia and Lym-phoma, 31, 578–582.
   Google Scholar
• McKeithan, T.W. (1990) "Molecular biology of Non-Hodgkin's lymphoma", Seminars in Oncology, 17, 30–42.
   Google Scholar
• Ohshima, A., Miura, I., Hashimoto, K., Takahashi, N., Utsumi, S., Nimura, T., et al. (1997) "Rearrangements of the BCL6 gene and chromosome aberrations affecting 3q27 in 54 patients with non-Hodgkin's lymphoma", Leukemia and Lymphoma, 27, 329 — 334.
   Google Scholar
• Ngan, B.-Y., Chen-Levy, Z. and Weiss, L.M. (1988) "Expression in non-Hodgkin's lymphoma of the bc1-2 protein associated with the t(14;18) chromosomal translocation", New England Journal of Medicine, 318, 1638–1641.
   Web of Science ®Google Scholar
• Gronbaek, K., Straten, P., Ralfkiaer, E., Ahrenkiel, V., Andersen, M.K., Hansen, N.E., et al. (1998) "Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity", Blood, 92, 3018 — 3024.
   Google Scholar
• Bairey, 0., Zimra, Y., Shaklai, M., Okon, E. and Rabizadeh, E. (1999) "Bc1-2, Bcl-X, Bax and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas", Clinical Cancer Research, 5, 2860–2866.
   PubMed Web of Science ®Google Scholar
• Aguiar, R.C.T., Yakushijin, Y., Kharbanda, S., Salgia, R., Fletcher, J.A. and Shipp, M.A. (2000) "BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration", Blood, 96, 4328–4334.
   Google Scholar
• Alizadeh, A., Eisen, M., Davis, R.E., Ma, C., Lossos, IS., Rosenwald, A., et al. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403, 503 — 511.
   Google Scholar
• Shipp, MA., Ross, K.N., Tamayo, P., Weng, A.P., Kutok, J., Aguiar, R.C.T., et al. (2002) "Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning", Nature Medicine, 8, 68–74.
   Google Scholar
• Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R., etal. (2002) "The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma", New England Journal of Medicine, 346, 1937–1947.
   Web of Science ®Google Scholar
• Huerta-Zepeda, A., Talavera, A., Aviles, A., Neri, N. and Mayani, H. (2000) "In vitro hematopoiesis in patients with malignant lymphoma during active disease and at complete clinical remission after chemotherapy", Leukemia and Lymphoma, 39, 613–624.
   Google Scholar
• Mayani, H., Guilbert, L.J. and Janowska-Wieczorek, A. (1992) "Biology of the hemopoietic microenvironment", European Journal of Haematology, 49, 225–233.
   PubMed Web of Science ®Google Scholar
• Harris, N.L., Jaffe, ES., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, ML., et al. (1994) "A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group", Blood, 84, 1361–1365.
   Google Scholar
• Hiddeman, W., Longo, DL., Coiffier, B., Fisher, RI., Cabanillas, F., Cavalli, F., et al. (1996) "Lymphoma classification—The gap between biology and clinical management is closing", Blood, 88, 4085–4089.
   Google Scholar
• Avilés, A., Calva, A., Diaz-Maqueo, J.C., Talavera, A., Huerta-Guzmán, J. and Vasquez, E. (1997) "Dose escalation of epirubicin in the CEOP-BLEO regimen: A controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma", Leukemia and Lymphoma, 25, 319–325.
   Google Scholar
• Flores-Guzman, P., Gutierrez-Rodriguez, M. and Mayani, H. (2002) "In vitro proliferation, expansion and differentiation of a CD34 + cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytolcines", Archives of Medical Research, 33, 107 — 114.
   Google Scholar
• Mayani, H. (1996) "Compositon and function of the hemopoietic microenvironment in human myeloid leukemia", Leukemia, 10, 1041–1047.
   Google Scholar
• Soligo, D.A., Lambertenghi Delilieris, G., Servida, F., Quirici, N., Campiglio, S., Tagliaferri, E., et al. (1998) "Hematopoietic abnormalities after autologous stem cell transplantation in lympho-ma patients", Bone Marrow Transplantation, 21, 15 — 22.
   Google Scholar
• Podesta, M., Piaggio, G., Frassoni, F. and Bacigalupo, A. (1998) "The assessment of the hematopoietic reservoir after immunosup-pressive therapy or bone marrow trasnplantation in severe aplastic anemia", Blood, 91, 1959— 1965.
   Google Scholar
• Martinez-Jaramillo, G., Sanchez-Valle, E., Gomez-Morales, E., Montesinos, ii., Valencia, I., Pizzuto-Chavez, J., et al. (2000) "Sequential variations in the content of bone marrow colony-forming cells in individual patients with aplastic anemia before and after immunosuppressive therapy", Hematology, 5, 247–255.
   Google Scholar
• Testa, N.G. and Gale, R.P., eds. (1988) "Hematopoiesis: Long-term effects of chemotherapy and radiation. New York: Marcel Dekker.
   Google Scholar
• Yao, M., Fouillard, L., Lemoine, F., Bouchet, S., Firat, H., Andreu, G., et al. (2000) "Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lympho-ma: no evidence of concomitant expansion of contaminating bc12/ JH-positive lymphoma cells", Bone Marrow Transplantation, 26, 497— 503.
   PubMed Web of Science ®Google Scholar
• Macintyre, E.A., Belanger, C., Debert, C., Canioni, D., Turhan, AG., Azaury, M., et al. (1995) "Detection of clonal CD34 ±/ CD19± progenitors in bone marrow of BCL-2IgH-positive folli-cular lymphoma patients", Blood, 86, 4691–4697.
   PubMed Web of Science ®Google Scholar
• Voso, MT., Hohaus, S., Moos, M. and Haas, R. (1997) "Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34 + cells and their CD19 subsets in patients with follicular lymphoma", Blood, 89, 3763–3768.
   PubMed Web of Science ®Google Scholar